Voronoi, Inc. Logo

Voronoi, Inc.

Develops selective kinase inhibitors and targeted protein degraders for precision oncology.

310210 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 에스동 18층, 연수구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Voronoi, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of novel therapeutics, with a primary focus on precision medicine for oncology. The company's expertise lies in creating innovative kinase inhibitors and targeted protein degraders. Voronoi leverages its proprietary drug discovery platform, VORONOMICS™, to rapidly identify and optimize drug candidates. This platform is designed to develop therapies with high selectivity and the ability to penetrate the brain barrier. Its pipeline includes targeted treatments for various cancers, such as non-small cell lung cancer (NSCLC) and HER2-positive solid tumors, aiming to accelerate the delivery of new therapies from design to the clinic.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Voronoi, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-18 00:00
M&A Activity
투자판단관련주요경영사항 (VRN04 프로그램 연구에 대한 옵션 행사 및 자산 구매 계약 체결)
Korean 10.7 KB
2025-09-08 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 125.2 KB
2025-09-05 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 121.8 KB
2025-09-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 120.3 KB
2025-08-20 00:00
Legal Proceedings Report
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (표피성장인자 수용체EGFR 돌연변이 비소세포폐암NSCLC 환자…
Korean 19.9 KB

Automate Your Workflow. Get a real-time feed of all Voronoi, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Voronoi, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ToolGen Incorporated Logo
A biotech firm licensing genome editing patents for therapeutics and agriculture.
South Korea 199800
Trainers´ House Oyj Logo
Consulting & coaching firm driving growth via leadership, sales & strategy execution.
Finland TRH1V
TRAJANO Logo
Provides strategic consulting and innovative business solutions.
Spain YTRA
Transgene Logo
Developing viral immunotherapies like vaccines and oncolytic viruses to treat solid tumors.
France TNG
TRANS GENIC GROUP INC. Logo
Offers drug discovery CRO services (gene editing, trials) and business investment/consulting.
Japan 2342
True Data Inc. Logo
A big data platform offering consumer purchasing analytics from Japan's largest ID-POS data network.
Japan 4416
Tsubota Laboratory Incorporated Logo
Developing pharmaceuticals and medical devices for ophthalmic and brain diseases.
Japan 4890
Tvardi Therapeutics Inc. Logo
Clinical-stage biopharma developing oral STAT3 inhibitors for fibrotic diseases.
United States of America TVRD
TWOSTONE&Sons Inc. Logo
An engineer platform providing IT talent and marketing services for corporate digital transformation.
Japan 7352
UJU Holding Limited Logo
AI-driven, full-link short-video marketing solutions for enterprises in China.
Hong Kong 1948

Talk to a Data Expert

Have a question? We'll get back to you promptly.